| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | General Counsel | General Counsel &SVP Bd
2 companies
Freitag Gregory Gene is a Director at Axogen, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 11 sells.
Estimated insider holdings value: $12.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | PDSB Pds Biotechnology Corp | Director | Buy | 15,060 | $1.66 | $24,999.60 | +32.6% | +5.3% | -49.2% | |
| Mar 7, 2024 | AXGN Axogen, Inc. | Director | Sell | 25,000 | $9.00 | $225,000.00 | -8.4% | -22.4% | +96.6% | |
| Jun 1, 2023 | AXGN Axogen, Inc. | Director | Sale+OE | 41,980 | $8.71 | $365,780.20 | -6.4% | -26.0% | -20.9% | |
| May 23, 2023 | AXGN Axogen, Inc. | Director | Sell | 7,468 | $9.23 | $68,899.16 | -1.1% | -34.9% | -32.5% | |
| Nov 14, 2022 | AXGN Axogen, Inc. | Director | Sell | 13,000 | $12.74 | $165,620.00 | -3.7% | -26.9% | -54.0% | |
| Nov 8, 2022 | AXGN Axogen, Inc. | Director | Sell | 13,000 | $12.50 | $162,500.00 | -3.6% | -22.7% | -55.2% | |
| Aug 10, 2022 | AXGN Axogen, Inc. | Director | Sell | 8,886 | $9.70 | $86,158.66 | -2.4% | +20.6% | -37.5% | |
| Aug 8, 2022 | AXGN Axogen, Inc. | Director | Sell | 37,046 | $10.54 | $390,647.02 | -4.6% | +2.8% | -35.8% | |
| Jun 15, 2021 | PDSB Pds Biotechnology Corp | Director | Buy | 5,882 | $8.50 | $49,997.00 | +14.6% | +62.9% | -64.9% | |
| Feb 25, 2021 | AXGN Axogen, Inc. | Director | Sell | 24,000 | $22.06 | $529,440.00 | -9.5% | -7.6% | -56.4% |